Cereno Scientific AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	44.27	80.9	49.28	57.54	44.81
Revenue	44.27	80.9	49.28	57.54	44.81
Revenue Growth (YoY)	-45.28%	64.18%	-14.36%	28.42%	444.85%
Gross Profit	44.27	80.9	49.28	57.54	44.81
Selling, General & Admin	117.74	154.5	89.9	84.12	59.57
Other Operating Expenses	0.35	-	3.6	-	-
Operating Expenses	118.88	154.78	93.51	84.13	59.59
Operating Income	-74.6	-73.88	-44.24	-26.6	-14.78
Interest Expense	-44.55	-26.09	-5.3	-0.46	-1.25
Interest & Investment Income	1.4	2.4	1.84	0.31	0
Currency Exchange Gain (Loss)	-	-1.96	-0.41	-0.9	-0.23
Pretax Income	-117.75	-99.53	-48.11	-27.65	-16.25
Income Tax Expense	-	-	-	0.01	0
Net Income	-117.75	-99.53	-48.11	-27.65	-16.25
Net Income to Common	-117.75	-99.53	-48.11	-27.65	-16.25
Shares Outstanding (Basic)	296	282	234	138	105
Shares Outstanding (Diluted)	296	282	234	138	105
Shares Change (YoY)	5.11%	20.50%	70.00%	30.64%	44.58%
EPS (Basic)	-0.40	-0.35	-0.21	-0.20	-0.15
EPS (Diluted)	-0.40	-0.35	-0.21	-0.20	-0.15
Free Cash Flow	-111.93	-107.29	-36.92	-18.62	-13.14
Free Cash Flow Per Share	-0.38	-0.38	-0.16	-0.14	-0.13
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-168.50%	-91.32%	-89.78%	-46.22%	-32.99%
Profit Margin	-265.97%	-123.02%	-97.63%	-48.06%	-36.28%
Free Cash Flow Margin	-252.82%	-132.62%	-74.91%	-32.35%	-29.32%
EBITDA	-73.81	-73.59	-44.22	-26.58	-14.77
EBITDA Margin	-166.72%	-90.96%	-89.75%	-46.20%	-32.96%
D&A For EBITDA	0.79	0.29	0.01	0.01	0.01
EBIT	-74.6	-73.88	-44.24	-26.6	-14.78
EBIT Margin	-168.50%	-91.32%	-89.78%	-46.22%	-32.99%
Revenue as Reported	44.27	80.9	49.28	57.54	44.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.